AN1 — Anagenics Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapTurnaround

Annual balance sheet for Anagenics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.28	2.57	1.62	0.396	0.577
Net Total Accounts Receivable
Net Total Receivables	0.921	1.09	0.651	0.575	0.805
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.77	6.25	3.83	1.94	2.74
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.691	0.836	0.412	0.211	0.05
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets	12.9	11.1	6.19	4.1	4.75
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.66	1.71	3.17	2.19	0.521
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.64	2.22	3.48	2.28	0.521
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.29	8.9	2.71	1.83	4.23
Total Liabilities & Shareholders' Equity	12.9	11.1	6.19	4.1	4.75
Total Common Shares Outstanding